Cover Image

Pathophysiologic basis of contrast enhancement in breast tumors

While the diagnostic benefits of gadolinium (Gd)‐chelate contrast agents are firmly established in magnetic resonance imaging (MRI) of tumors, the pathophysiologic basis of the enhancement observed and its histopathologic correlate remained vague.

Saved in:
Bibliographic Details
Main Authors: Knopp, Michael V. (Author) , Winkler, Eva C. (Author) , Sinn, Peter (Author) , Mattern, Jürgen (Author) , Junkermann, Hans (Author) , Radeleff, Jannis (Author) , Magener, Achim (Author) , Brix, Gunnar (Author) , Delorme, Stefan (Author) , Kaick, Gerhard van (Author)
Format: Article (Journal)
Language:English
Published: 01 October 1999
In: Journal of magnetic resonance imaging
Year: 1999, Volume: 10, Issue: 3, Pages: 260-266
ISSN:1522-2586
DOI:10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7
Get full text
Author Notes:M.V. Knopp, E. Weiss, H.P. Sinn, J. Mattern, H. Junkermann, J. Radeleff, A. Magener, G. Brix, S. Delorme, I. Zuna, and G. van Kaick
Description
Summary:While the diagnostic benefits of gadolinium (Gd)‐chelate contrast agents are firmly established in magnetic resonance imaging (MRI) of tumors, the pathophysiologic basis of the enhancement observed and its histopathologic correlate remained vague.
Item Description:Gesehen am 18.02.2021
Physical Description:Online Resource
ISSN:1522-2586
DOI:10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7

Similar Items